alternative lipid sources are non-marine and lack long-chain polyunsatured fatty acids (LC-PUFA).
Some freshwater species have little or no requirement for dietary LC-PUFA. However, the majority of 54 aquatic marine species have a defined dietary requirement for LC-PUFA (reviewed by Glencross, 2009 ). This probably results from an evolutionary adaptation to naturally LC-PUFA rich diets, resulting in many marine species losing their ability to convert C18 n-6 and n-3 PUFA into the 57 corresponding C20 and C22 n-3 and n-6 HUFA in vivo by alternating cycles of desaturation and elongation (Tocher, 2010) . Marine and catadromous species, including barramundi, have been demonstrated to have an absolute dietary requirement for the longer, and more unsaturated 20:5n-3 60 (EPA) and 22:6n-3 (DHA; Buranapanidgit et al., 1988; Williams et al., 2006; Glencross and Rutherford, 2011) . A total n-3 LC-PUFA inclusion level of between 10 -17 g kg -1 (as a combination of 20:5 n-3 and 22:6 n-3) was sufficient to support growth of barramundi (Buranapanidgit et al., 1988, 63 1989 cited by Boonyaratpalin, 1997 . Although in that study all diets were 4 pair-fed restrictively and it is unclear as to what effect that this feed ration regime had on the outcomes of the study. However in that study, a subcutaneous haemorrhaging, observed as a 72 reddening of the skin certain parts of in fish, occurred as dietary DHA levels increased from 1 to 18 g kg -1 , which was ameliorated by the inclusion of 10 g kg -1 EPA. These results highlighted the importance not only of the absolute dietary inclusion level, but also the influence of other EFAs in the 75 diet. The authors concluded, based on their study and that of Williams et al. (2006) that the total LC-PUFA inclusion level for barramundi could be reduced to at least 12 g kg -1 provided the DHA and EPA are held in balance (i.e. a 1:1 ratio). However, it was suggested that further research was 78 required to better define the EPA requirements, and the optimal ratio of DHA:EPA in the diets of barramundi.
81
To address some of these questions an experiment was conducted to examine the effects of different DHA and EPA inclusion levels, total LC-PUFA inclusion levels and the effects of fixed or satietal rations, to further refine the understanding of the requirements of LC-PUFA by barramundi. This study consisted of six dietary treatments of a range of inclusion levels of DHA both with and without EPA ( Table 1) . Each of these diets was restrictively pair-fed to eliminate effects of feed 90 intake variation as a secondary variable. Two additional treatments consisted of those diets containing 1 g kg -1 DHA + 1 g kg -1 EPA and 10 g kg -1 DHA + 1 g kg -1 EPA, which were each fed to apparent satiety. These additional treatments were included to measure the effect of varying feed intake on the 93 results achieved relative to the pair-fed strategy. Table 2 ). Diets were manufactured by making a single 40 kg batch of extruded pellets 117 before an oil coating was applied under vacuum to each treatment. Dry ingredients were mixed using an upright planetary mixer (Robo Coupe, Vincennes Cedex, France).
120
Following dry mixing, the base diet was extruded using an APV MFP24 laboratory scale twin-screw extruder (APV-Baker, Peterborough, UK) using the operational configuration as described in Glencross et al. (2012) . The pellets were produced by delivering the dry mash into the barrel at a feed 123 rate of around 20 kg h -1 . Barrel temperatures were set for each of the four zones from drive to die at 50, 80, 100 and 110°C respectively. Water was peristaltically pumped (Baoding Longer Precision Pump Co., Ltd, Hebei, China) into the barrel at 82 mL min -1 . Feeds were extruded through a 4mm Ø 6 die with the machine running at c. 470 rpm. Pellets were cut into 6-7 mm lengths using two-bladed collected and dried at 65°C prior to coating with oil.
Specific lipid allocations, consisting of blends of butter, olive oil, DHA oil and fish oil (Table 1),   132 were vacuum-infused into the pellets after warming both the oils and pellets in an oven at 60°C for 1 h. Warmed pellets were then placed in a Hobart mixer and the prescribed oil blend for each treatment was poured over the pellets whilst mixing. After mixing, the pellets were then exposed to a vacuum 135 through the application of a perspex lid with a rubber seal to the mixing bowl and a vacuum pump connected to a valve in the lid. After all pellets were vacuum-infused with their respective oil blend, the pellets were stored at -20°C until required for feeding.
138
Fish were fed once daily between 0900 and 1030 each day. The fish were fed diets in a restricted pairfed regime to minimise feed intake variability among treatments, thereby ensuring that any effects 141 seen on the fish were due solely due to diet composition and not possible confounding intake variability effects. Any uneaten feed was accounted for to accurately determine feed intake by each tank of fish (Helland et al., 1996) . A correction factor was applied to recovered uneaten pellets to 144 account for soluble losses incurred on the pellet between feeding and collection to make a more accurate feed intake assessment. The initial restrictive rations were defined based on the feed demand as estimated for a 17.0 MJ kg -1 diet and fish of 16 g at 30ºC using a published bioenergetic model for 147 this species (Glencross, 2008 Total lipid content of the diets was determined gravimetrically following extraction of the lipids using chloroform: methanol (2:1) described by Folch et al. (1957) . Gross ash content was determined gravimetrically following loss of mass after combustion of a sample in a muffle furnace at 550C for 168 12 h. Gross energy was determined by adiabatic bomb calorimetry. Fatty acids were analysed as methyl ester derivatives. Lipids were esterified and analysed by gas chromatography (GC) using flame ionisation detection. Peaks were identified by comparing relative retention times to standards.
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Samples of whole fish combined by tank, were dried of residual surface moisture and minced together. For mincing, samples were passed twice through an industrial food processor to ensure 174 sample homogeneity. A sub-sample of mince was taken for dry matter analysis and an additional mince sub-sample was then frozen prior to being freeze-dried. Freeze-dried mince samples were milled and then analysed for dry matter, nitrogen, ash, total lipid, fatty acids and energy as described 177 above. No. HG1539). Trace elements were determined after mixed acid digestion using inductively coupled plasma atomic emission spectrophotometry (ICP-AES). 
Statistical analyses
All figures are mean ± SEM unless otherwise specified. Statistical differences were determined by 195 ANOVA and means compared using least significant differences using GenStat (Release 14, VSN International, Hemel Hempstead, UK) with P<0.05 considered significant. Additionally, the effect of ration level and diet were also analysed by two-way ANOVA using GenStat (Release 14, VSN   198 International, Hemel Hempstead, UK) with P<0.05 considered significant.
The retention of specific fatty acids (DHA and EPA) was calculated using the formula described by 201 Glencross et al. (2003) . Briefly, the percentage retention of fatty acids was calculated using the average feed intake per fish in each tank and the average gain in mass of each fatty acid by fish using the formula:
204
Where FAf is the absolute amount of a specific fatty acid in the fish at the end of the study, FAi is the absolute amount of that specific fatty acid in the fish at the beginning of the study, and FAc is the 207 amount of that specific fatty acid that the fish consumed over the study period. Initial and final fish weights, growth rate, feed intake, feed conversation ratio and survival parameters are presented in Table 3 . The poorest performing treatment increased their weight by 171% and the 213 best performing treatment increased their weight by 245% (Table 3) . Among the restricted fed groups, there was no effect of dietary DHA or EPA level on final weight, weight gain or growth rate.
However, final weight, weight gain and growth rate were higher (P<0.05) for the two satiety fed 216 groups, compared with the restricted fed groups, reflective of their greater (P<0.05) feed intake. There was no interaction between feeding regime (restricted or satiety) and dietary DHA levels (P>0.05).
Feed conversion and survival were all unaffected (P>0.05) by dietary DHA and EPA levels and 219 feeding regime (restricted or satiety).
Tissue composition and fatty acid retention 222
Dietary treatment significantly affected whole body fatty acid composition in the fish (P<0.05; Table   4 ). Compared with the initial fish, the majority of dietary treatment groups showed a reduction in whole body DHA (P<0.05) although fish fed diet D10E1 showed an increase in whole body DHA 225 compared with the initial fish (P<0.05). For restricted fed fish, increasing dietary DHA resulted in an increase in the observed whole body DHA, with the highest levels observed in fish fed diet containing D10E1 (P<0.05), followed by fish fed diet D5E1 (P<0.05) while the fish fed diets D3E1 and D1E1
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did not differ from each other in whole body DHA content (P>0.05). However, the whole body DHA content of these two groups was significantly lower than the D10E1 and D5E1 diet fed fish (P<0.05).
Fish from the D10E1 satiety fed treatment contained less (P<0. increased (P<0.05) for the D5E1, D10E10, D5E5 and both satiety fed groups (D1E1 and D10E10).
Significant differences were observed in whole body PUFA between treatments (P<0.05), with PUFA 249 concentration increasing with dietary DHA and EPA content for fish on the restricted feeding regime.
Compared with the initial fish, both satiety fed groups (D1E1 and D10E10) showed reduced levels of whole body PUFA along with most of the restricted fed fish, with the only group containing 252 significantly more PUFA than the initial fish being the D10E10 diet fed fish. The total LC-PUFA content ranged from 9.4 -14.6% (P<0.05), and increased with increasing dietary LC-PUFA content.
Compared with the initial fish, only the D10E1 and D10E10 dietary treatments showed an increase 255 (P<0.05) in tissue LC-PUFA content, all other groups showed a significant reduction in tissue LC-PUFA content (P<0.05).
258
Tissue n-3 levels were significantly lower for all dietary treatments compared with the initial fish (P<0.05). Tissue n-3 levels were increased (P<0.05) by increasing dietary DHA, as well as the combined concentration of DHA + EPA concentration in the diet (P<0.05). However, feeding regime
261
(restricted vs satiety) did not affect tissue n-3 levels (P>0.05). Tissue n-6 levels were similar between the initial fish and all fish fed diets with greater than 1 g kg -1 DHA (D1E1). However, the addition of with the initial fish, all fish fed diets containing greater than 1 g kg -1 EPA had reduced tissue n-6 levels (P<0.05). Again, feeding regime (restricted vs satiety) did not affect tissue n-6 levels (P>0.05).
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Retention of DHA and EPA is presented in Haematology and plasma chemistry parameters are presented in Table 5 . Dietary DHA and EPA inclusion levels did not affect haematological parameters such as PCV or erythrocyte fragility.
288
However, glutamine dehydrogenase and haemoglobin levels were affected by dietary treatment.
Glutamate dehydrogenase was significantly increased in fish that were fed DHA and EPA in a 1:1 ratio, regardless of the total dietary PUFA content (P<0.05) as well as being increased by satiety 291 feeding compared with the restricted fed groups (P<0.05).
For fish fed diets containing 1 g kg -1 EPA, increasing DHA content resulted in an increase in 294 haemoglobin (P<0.05). However, for fish fed DHA and EPA at a 1:1 ratio, the picture is less clear with the 10: 10 g kg -1 inclusion diet resulting in the highest haemoglobin levels, the D5E5 diet with the lowest and the D3E3 diet with an intermediary level. Haemoglobin levels were not affected by 297 feeding regime (P>0.05) and there were no significant differences in haptoglobin levels. 
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When the DHA: EPA ratio was extended to 5: 1 (total LC-PUFA 7 g kg -1 ) no effect on growth was observed, and for higher LC-PUFA levels (greater than 12 g kg -1 ), again no effect on growth was observed, even when the ratio was 10: Higher levels of DHA and EPA in the initial fish may explain differences between the present study 396 and that of Glencross and Rutherford (2011) . Fish of a similar starting size (17 g) but the initial fish in the present study contained 7.6% DHA and 3.4% EPA compared with 3% DHA and 2% EPA for Glencross and Rutherford (2011). Glencross et al. (2013) suggested that the effects of EFAs on 399 growth may be a function of time rather than just mass turnover (discussed previously), it is not surprising that the results of the present study differ to that of Glencross and Rutherford (2011) considering that the endogenous reserves of DHA and EPA were almost double in the present study. erythrocyte fragility). However, there was a large variation between individual fish from the same groups suggesting that individual variation is considerably larger than any dietary effect, or that there is no effect of dietary fatty acids in these parameters.
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Of the biochemical markers assessed only glutamate dehydrogenase and haemoglobin were significantly affected by dietary treatment. Glutamate dehydrogenase is an enzyme, present in the Catacutan and Coloso (1995) observed abnormal reddening of the fins, a sign of essential fatty acid 444 deficiency, in fish fed diets containing less than 5% lipid. Glencross and Rutherford (2011) also observed this reddening of fins, identifying it as mild subcutaneous haemorrhaging resulting from a reduced ability of the fish to ionically regulate. In this study it was identified that this was linked to 447 the absence of EPA in the diet, with high levels of DHA exacerbating the problem. In the present study this reddening was not observed, suggesting that the EPA inclusion levels were sufficient to facilitate ionic regulation, or that residual levels in the fish's body reserves were adequate to prevent ), suggesting that either the ARA content was sufficient to produce sufficient prostaglandin H2 in the present study but not that of Glencross and Rutherford (2011) . Fish in the present study contained substantially higher tissue levels 456 of ARA and EPA than those used by Glencross and Rutherford (2011) and utilisation of these stored reserves may have contributed to the production of sufficient prostaglandin H2 for ionic regulation.
Conversely, as the dietary EPA + ARA concentration is less than that of Glencross and Rutherford (2011) , it raises the possibility that the majority of ionic regulation was mediated through pathways other than the prostaglandin hormones, such as gills, kidneys or intestine (Glencross, 2006) . Further research examining the activity of these pathways is required to confirm this. did not result in a range of physiological problems suggesting that further research is required to elucidate differences between this study and previous ones. It is generally suggested that DHA and 468 EPA should be provided in balance although the results of the present study suggest that is less important than previously thought. Given the lack of deleterious effects on growth and health of fish fed the D1E1 diet, further studies are warranted and should examine lower levels of DHA and EPA 471 inclusion as well as examining the effect of altering the DHA: EPA ratio beyond 10:1 or below 1:1.
Given that the response of the juvenile barramundi to low-LC-PUFA diets may be related to time and/or turnover, studies should be lengthened and the range of health parameters expanded to fully 474 assess the longer-term implications on growth and health.
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